
Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.

Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.
Author: PANews
This content is for informational purposes only and does not constitute investment advice.